Intec Pharma Top Management
Intec Pharma employs about 36 people. The company is managed by 14 executives with a total tenure of roughly 108 years, averaging almost 7.0 years of service per executive, having 2.57 employees per reported executive. Evaluation of Intec Pharma's management performance can provide insight into the firm performance.
John Kozarich Chairman Chairman of the Board |
Jeffrey Meckler Chairman CEO, Vice Chairman of the Board |
Intec |
Intec Pharma Workforce Comparison
Intec Pharma is considered to be number one stock in number of employees category among related companies. The total workforce of Biotechnology industry is now estimated at about 132,291. Intec Pharma adds roughly 36.0 in number of employees claiming only tiny portion of stocks in Biotechnology industry.
Intec Pharma Notable Stakeholders
An Intec Pharma stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Intec Pharma often face trade-offs trying to please all of them. Intec Pharma's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Intec Pharma's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Zvika Joseph | Co-Founder and Chairman | Profile | |
John Kozarich | Chairman of the Board | Profile | |
Jeffrey Meckler | CEO, Vice Chairman of the Board | Profile | |
Liat Flaishon | Vice President-Clinical and Business Development | Profile | |
Nir Sassi | Vice President - Finance | Profile | |
Oren Mohar | CFO | Profile | |
Nadav Navon | Executive VP of RandD and Operations | Profile | |
Roger Pomerantz | Director | Profile | |
Issac Silberman | Independent Director | Profile | |
William Hayes | Director | Profile | |
Gil Bianco | Independent Director | Profile | |
Giora Carni | Director | Profile | |
Michael Gendreau | Chief Medical Officer | Profile | |
Walt Linscott | Chief Administrative Officer | Profile |
Intec Pharma Workforce Analysis
Traditionally, organizations such as Intec Pharma use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Intec Pharma within its industry.Intec Pharma Manpower Efficiency
Return on Intec Pharma Manpower
Net Loss Per Employee | 402.5K | |
Net Loss Per Executive | 1M | |
Working Capital Per Employee | 3.5M | |
Working Capital Per Executive | 8.9M |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. Note that the Intec Pharma information on this page should be used as a complementary analysis to other Intec Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Consideration for investing in Intec Stock
If you are still planning to invest in Intec Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Intec Pharma's history and understand the potential risks before investing.
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |